Ester Mejstrikova, M.d., Ph.d.

Ester Mejstrikova, M.D., Ph.D.

2. lékařská fakulta Univerzity Karlovy

Discovery Awards 2015 - MUDr. Ester Mejstříková, Ph.D., CLIP

discoveryaward eu

Esther Liu, M.D.

Providence Swedish

Prognostic relevance of monocytic switch and future research

VJHemOnc – Video Journal of Hematology & HemOnc

The Stroke Preclinical Assessment Network (SPAN)

Susan Emeigh Hart VMD PhD, "A primer of collagen biology..." 2010 Miami Dupuytren Symposium

Dupuytren Research Group

Frequency Specific Microcurrent in healing - MIT EE Susan Downs MD

Leukocyte telomere length and disability in MS

PHARMAC seminar: Women's health 2019, 3a of 6, PCOS

Meet a scleroderma investigator: Suzanne C. Li, M.D., Ph.D.

National Scleroderma Foundation

Targeting underlying pathobiology of ESCC: emerging immunotherapies on future clinical practice

Touch Medical Media

What is the relationship between Scleroderma and PH

Evaluating response to treatment in patients with EMD

VJHemOnc – Video Journal of Hematology & HemOnc

Disability assessment and quantification in people with severely affected MS

NUR 601 Lesson 6 Intro and Thyroid Meds

Patricia Thompson-Leavitt

Initial high-efficacy disease-modifying therapy in multiple sclerosis

Lipid-based therapies for MS

Clinical Illness Including MIS-C | Elizabeth Whittaker, PhD, DTM&H, MRCPCH

Academic Medical Education

Professor Dimitrios Karussis on Treating MS

Dimitrios Karussis